Sichenzia Ross Ference Carmel LLP represents Lexaria Bioscience Corp. in $5 Million Registered Direct Offering and Concurrent Private Placement

By Sichenzia Ross Ference LLP | October 15, 2024

Press Release – New York, NY – October 15, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, in a $5 million registered direct offering and private placement priced at-the-market under Nasdaq rules. Gross proceeds to the company will be approximately $5 million.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

The SRFC team was led by partners Gregory Sichenzia and Avital Perlman and associates Rohini Sud and Benasz Hansotia.

Posted in News, Press Releases, Transactions and tagged Avital Perlman, Benasz Hansotia, capital markets, gregory sichenzia, Lexaria Bioscience Corp., rohini sud